1. I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response

   • Donika Plyku
   • Robert F. Hobbs
   • Douglas Van Nostrand

   Original Article 04 February 2022 Pages: 213 - 223

   

2. Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab

   • Florian Eude
   • Florian Guisier
   • Pierre Decazes

   Original Article 21 January 2022 Pages: 224 - 234

   

3. Feasibility of ¹²⁵I-RGD uptake as a marker of angiogenesis after myocardial infarction

   • Takafumi Yamase
   • Junichi Taki
   • Seigo Kinuya

   Original Article 26 November 2021 Pages: 235 - 243

   

4. Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting

   • Motoko Morishima
   • Tomonari Kiriyama
   • Yosuke Ishii

   Original Article Open access 25 November 2021 Pages: 244 - 254

   

5. Correction to: Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting

   • Motoko Morishima
   • Tomonari Kiriyama
   • Yosuke Ishii

   Correction Open access 13 December 2021 Pages: 255 - 255

6. Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma

   • Kun-Han Lue
   • Sung-Chao Chu
   • Shu-Hsin Liu

   Original Article 24 November 2021 Pages: 256 - 266

   

7. An open-label, single-arm, multi-center, phase II clinical trial of single-dose [¹³¹I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma

   • Anri Inaki
   • Tohru Shiga
   • Seigo Kinuya

   Original Article Open access 06 December 2021 Pages: 267 - 278

   

8. Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test

   • Yoshiaki Miyazaki
   • Masashi Kameyama
   • Nobuyuki Tabata

   Original Article Open access 01 January 2022 Pages: 279 - 284

   

9. A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients

   • Miwako Takahashi
   • Shuntaro Yoshimura
   • Taiga Yamaya

   Original Article Open access 29 November 2021 Pages: 285 - 292

   

10. Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging

    • Katharina Kessel
    • Robert Seifert
    • Kambiz Rahbar

    Original Article Open access 02 December 2021 Pages: 293 - 301

    

11. Detection efficacy of PET/CT with ¹⁸F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study

    • Tomoaki Otani
    • Tsuneo Saga
    • Yuji Nakamoto

    Original Article 22 January 2022 Pages: 302 - 309

    

12. Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses

    • Ayşegül Aksu
    • Özge Vural Topuz
    • Burçak Yılmaz

    Original Article 06 January 2022 Pages: 310 - 318

    

13. Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo

    • Yoichi Shimizu
    • Sho Koyasu
    • Yuji Nakamoto

    Short Communication 16 January 2022 Pages: 319 - 326

    

14. Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy

    • Wajana Thaweerat

    Letter to the Editor 30 January 2022 Pages: 327 - 328